HDL is the “good” cholesterol, and LDL is the “bad” cholesterol. HDL picks up excess cholesterol in your blood and carries it back to your liver, which flushes it from your body. LDL does the opposite: when levels get too high, it deposits cholesterol into the walls of your arteries, forming plaque that raises your risk of heart disease and stroke.
That simple framing is useful, but the full picture is more nuanced. Not all HDL is equally protective, LDL particle count may matter more than the number on your standard lab panel, and some cholesterol risk factors can’t be changed with diet or exercise at all.
What LDL Actually Does to Your Arteries
LDL particles carry cholesterol from the liver out to your cells. Your body needs some of this delivery system to function. The problem starts when there’s more LDL circulating than your cells need. The excess particles slip into the walls of your arteries, where they get trapped and chemically modified through oxidation. Once modified, they trigger an immune response: white blood cells rush in to clean up the damage, absorb the oxidized LDL, and balloon into what researchers call foam cells. Layer upon layer of these foam cells, along with calcium and other debris, form the hardened plaque that narrows arteries over time.
This process, called atherosclerosis, is slow. It can develop over decades before causing symptoms. But the stakes are high: plaque buildup is the underlying cause of most heart attacks and many strokes. Keeping LDL low is one of the most direct ways to slow it down.
How HDL Protects You
HDL particles work as a cleanup crew. They absorb cholesterol floating in your bloodstream and ferry it back to the liver for disposal, a process called reverse cholesterol transport. Higher HDL levels are associated with lower rates of heart disease and stroke.
But here’s where things get complicated. For years, doctors assumed that raising HDL levels would automatically lower heart disease risk. Clinical trials designed to increase HDL concentrations with drugs have consistently failed to reduce cardiovascular events. Genetic studies have reinforced this finding: people born with naturally higher HDL levels don’t necessarily have less heart disease than expected. The strong link between low HDL and heart disease in population studies likely reflects the fact that low HDL tends to travel with other risk factors, particularly high levels of triglyceride-rich particles that are themselves harmful.
In other words, HDL on your lab report is a useful marker for assessing risk, but artificially boosting it doesn’t seem to help. The quality and function of your HDL particles may matter more than the raw number.
What Your Numbers Should Look Like
A standard lipid panel reports your cholesterol in milligrams per deciliter (mg/dL). The targets that matter most:
- LDL: About 100 mg/dL is considered optimal. Lower is generally better, especially if you already have heart disease or multiple risk factors.
- HDL: At least 40 mg/dL for men and 50 mg/dL for women. Higher levels are associated with better outcomes, though as noted above, chasing a higher number with medication hasn’t proven beneficial.
- Non-HDL cholesterol: Less than 130 mg/dL for most people. This is calculated by subtracting your HDL from your total cholesterol and captures all the potentially harmful particles in one number. Many clinicians now consider this more useful than the total-to-HDL ratio.
You can also calculate your cholesterol ratio by dividing total cholesterol by HDL. If your total is 200 and your HDL is 50, your ratio is 4:1. Higher ratios mean higher risk. But non-HDL cholesterol is increasingly preferred as a single summary metric.
Why Standard LDL Testing Can Miss Risk
The LDL number on your lab report estimates the total amount of cholesterol carried by LDL particles. It doesn’t tell you how many particles are carrying it. Two people with identical LDL cholesterol levels can have very different numbers of LDL particles, and the person with more particles faces greater risk because each particle is a separate opportunity to penetrate an artery wall.
A test called apolipoprotein B (apoB) counts the actual number of harmful particles in your blood. The European Society of Cardiology concluded in 2019 that apoB is a more accurate marker of cardiovascular risk than standard LDL cholesterol, and four major clinical reports published since 2021 have reinforced that conclusion. The gap between the two tests is especially important for people already on cholesterol-lowering medication. Statins reduce the cholesterol content per particle more than they reduce particle count, so your LDL number can look reassuringly low while your actual particle-driven risk remains higher than expected. If your doctor orders an apoB test, that’s why.
A Genetic Wild Card: Lipoprotein(a)
There’s a lesser-known particle called lipoprotein(a), or Lp(a), that behaves like LDL and builds up in artery walls the same way. Unlike regular LDL, Lp(a) levels are almost entirely determined by genetics. Healthy eating and exercise won’t budge them. About one in five people has elevated Lp(a), and most have never been tested for it because it’s not included in a standard lipid panel.
If you have a family history of early heart disease and your standard cholesterol numbers look fine, Lp(a) is worth asking about. There are no approved treatments specifically for lowering it yet, but knowing your level helps you and your doctor manage every other risk factor more aggressively. Maintaining a healthy weight, staying active, and not smoking all still reduce your overall cardiovascular risk even when Lp(a) itself doesn’t change.
What Actually Moves the Numbers
LDL responds meaningfully to lifestyle changes. Replacing saturated fats (butter, red meat, full-fat dairy) with unsaturated fats (olive oil, nuts, fatty fish) lowers LDL. So does eating more soluble fiber from foods like oats, beans, and barley. Regular aerobic exercise has a modest effect on LDL but a more noticeable one on HDL, typically raising it by a few points. Losing excess weight improves nearly every lipid marker.
When lifestyle changes aren’t enough, cholesterol-lowering medications are among the most studied drugs in medicine. They work primarily by reducing LDL and the total number of harmful particles in circulation. The benefit scales with how much LDL drops: the lower it goes, the fewer particles are available to enter artery walls.
HDL is harder to manipulate on purpose. Exercise and moderate alcohol intake raise it slightly, but as clinical trials have shown, pharmaceutical attempts to push HDL higher haven’t translated into fewer heart attacks. The current thinking is that HDL is best viewed as a signal, not a target. A naturally high HDL is a good sign. A low HDL should prompt attention to everything else on the panel, especially triglycerides and LDL particle count.